Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
about
Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive ReviewInsights into the role of immunosenescence during varicella zoster virus infection (shingles) in the aging cell modelRisk of Stroke and Myocardial Infarction After Herpes Zoster in Older Adults in a US Community Population.Risk Factors for Herpes Zoster Among AdultsA systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events.Shingles (Herpes Zoster) Vaccine (Zostavax(®)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia.Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.Self-reported herpes zoster, pain, and health care seeking in the Health and Retirement Study: implications for interpretation of health care-based studies.Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.Studies with herpes zoster vaccines in immune compromised patients.Effectiveness of herpes zoster vaccination in an older United Kingdom population.A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profileEfficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis
P2860
Q26748712-729092E0-8A5F-4B79-9629-2F3A3BECC2E4Q36546343-CC57B6CE-44C9-437A-A0CD-A02A6D2EE6EEQ36868945-97256881-ACD4-44DD-ABB9-74BC02443920Q37057336-68E2FDBA-CE13-4FC5-A48B-27B13FFC4EE3Q38657532-01104A7B-E6E6-409F-A140-3701992441DFQ38836789-FF012536-1627-4BD3-B03A-5103E44E4D74Q38864559-B84D643C-8A2D-46A6-AD01-DD39DEEA74B5Q39765566-7622D947-869A-4195-AA94-A201FA8BAF5FQ40437635-5A132092-60CA-44FA-91CF-4713239DE8E3Q47155538-0DF22247-8E8D-4096-84ED-C163E67BA5BCQ47605669-E9F5FF26-553D-4271-90E6-1BF21A7D3E8BQ52648252-F5C15CCA-E687-4C37-816A-78CA69F9ABADQ56888201-AD99EEDC-BCC2-4213-9CA0-F338812B317CQ58553251-22A6043F-DC0A-487C-9062-73C437BC5F20
P2860
Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Herpes zoster vaccine effectiv ...... ed pain by vaccination status.
@ast
Herpes zoster vaccine effectiv ...... ed pain by vaccination status.
@en
type
label
Herpes zoster vaccine effectiv ...... ed pain by vaccination status.
@ast
Herpes zoster vaccine effectiv ...... ed pain by vaccination status.
@en
prefLabel
Herpes zoster vaccine effectiv ...... ed pain by vaccination status.
@ast
Herpes zoster vaccine effectiv ...... ed pain by vaccination status.
@en
P2093
P2860
P1476
Herpes zoster vaccine effectiv ...... ed pain by vaccination status.
@en
P2093
Barbara P Yawn
Craig M Hales
John Zhang
Marge J Kurland
Mona Marin
Peter C Wollan
Rafael Harpaz
Stephanie R Bialek
P2860
P304
P356
10.1080/21645515.2015.1016681
P577
2015-01-01T00:00:00Z